Protocol-to-chart matching asset built inside authorised EHRs

Protocol-to-chart matching asset built inside authorised EHRs: every protocol's inclusion/exclusion criteria translated into transparent, editable rule-based screening logic (compound boolean logic, time windows, negations) and evaluated against live FHIR chart data on a daily refresh. The byproduct assets are (a) a library of normalised, machine-executable eligibility rule-sets per protocol/indication, (b) ranked candidate shortlists with the specific chart evidence attached to each criterion hit, and (c) the human-reviewer verdicts (confirmed / rejected) recorded on each machine match — a human-verified ground-truth layer over AI-identified eligibility.

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Mahalo and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Health Care Technology
Instruments: equities
Categories: AlternativeReference

Dataset card

Type: not stated
Format: Structured/JSON — FHIR and FHIR Bulk Data resources, plus rule-logic definitions and per-criterion evidence references
Volume: No published count. Structural estimate: one rule-set per active protocol/indication plus one eligibility evaluation per patient per protocol per day — so a site with ~50k-500k screened charts across a handful of concurrent studies yields 10^6-10^7 daily match evaluations, of which the durable asset is the rule library plus the reviewer-confirmed shortlists (order 10^3-10^5 reviewed candidates per site-year).
Users: N/A — no consumer or registered-user base: B2B deployment installed against a site's authorised EHR connection (company itself is a ~3-person San Francisco team).
History: 3 years
Update frequency: not stated
Growth: Active but early-stage / pre-scale: a ~3-person San Francisco company with no disclosed funding, shipping a live FHIR-integrated product with ~one-week setup. Treat as emerging — growing in capability (FHIR and FHIR Bulk paths, major-EHR support) but with a very small deployment footprint.
Launched: About 2022-2024 — the company organisation record dates to roughly 2022 and the product's certified-FHIR/FHIR-Bulk integration approach reflects the recent wave of EHR bulk-access capability rather than earlier HL7 v2 pipelines. Request further research to pin the first commercial deployment date.
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site